Dr. Douglas Tremblay of the Ichan School of Medicine explains the necessity of cytoreductive therapy for patients with MPNs such as essential thrombocythemia and polycythemia vera. Cytoreduction is ...

The association between residual tumor volume after primary cytoreduction and survival was less consistent in patients with low-grade serous ovarian carcinoma (LGSOC) compared with other histology ...

It would not be an exaggeration to state that the goal of attempting to surgically maximally cytoreduce diffuse intraperitoneal ovarian cancer represents one of the most unique standard-of-care ...

Feasibility and tolerability of multimodality treatment of locally advanced rectal cancer, particularly in elderly patients in a community cancer center. Background: Advance in chemotherapy for ...

Secondary surgical cytoreduction in women with platinum-sensitive, recurrent epithelial ovarian, primary peritoneal, or fallopian-tube (“ovarian”) cancer is widely practiced but has not been evaluated ...

Patients with advanced ovarian cancer who achieved complete cytoreduction had the best outcomes, regardless of the number of chemotherapy cycles before surgery. Increasing the number of chemotherapy ...

In advanced ovarian cancer, maximal efforts have to be attemptedto achieve optimal cytoreduction, as this represents the keystone in the therapeutic management. This large, prospective study aims at ...

As ovarian cancer is usually diagnosed at an advanced stage, it is associated with a poor prognosis. The initial standard treatment is surgery, with the aim of debulking the primary carcinoma and ...